|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA07010509
|
WE 16:0/4:0(2Me)
|
hexadecyl 2-methyl-butanoate
|
WE 21:0
|
C21H42O2
|
326.318481
|
|
LMFA07010509
|
WE 16:0/4:0(2Me)
|
hexadecyl 2-methyl-butanoate
|
WE 21:0
|
C21H42O2
|
326.318481
|
|
LMFA01090082
|
3,3-Dibromo-2-n-butylacrylic acid
|
2-(dibromomethylene)hexanoic acid
|
|
C7H10Br2O2
|
283.904750
|
|
LMFA01090082
|
3,3-Dibromo-2-n-butylacrylic acid
|
2-(dibromomethylene)hexanoic acid
|
|
C7H10Br2O2
|
283.904750
|
|
LMFA01090081
|
3-bromo-2Z-nonenoic acid
|
3-bromo-2Z-nonenoic acid
|
|
C9H15BrO2
|
234.025540
|
|
LMFA01090081
|
3-bromo-2Z-nonenoic acid
|
3-bromo-2Z-nonenoic acid
|
|
C9H15BrO2
|
234.025540
|
|
LMFA05000019
|
Panaxynol
|
1,9Z-heptadecadien-4,6-diyn-3-ol
|
FOH 17:6
|
C17H24O
|
244.182715
|
|
LMFA05000555
|
(3E,6Z)-3,6-Nonadien-1-ol
|
(3E,6Z)-nona-3,6-dien-1-ol
|
FOH 9:2
|
C9H16O
|
140.120115
|
|
LMFA01050432
|
(S)-3-hydroxyhexanoic acid
|
3S-hydroxyhexanoic acid
|
FA 6:0;O
|
C6H12O3
|
132.078645
|
|
LMFA01050431
|
Auricolic acid
|
14-hydroxy-11Z,17Z-eicosadienoic acid
|
FA 20:2;O
|
C20H36O3
|
324.266446
|
|
LMFA01050431
|
Auricolic acid
|
14-hydroxy-11Z,17Z-eicosadienoic acid
|
FA 20:2;O
|
C20H36O3
|
324.266446
|
|
LMFA01050527
|
threo-9,10-Dihydroxystearic acid
|
(9R,10R)-9,10-dihydroxyoctadecanoic acid
|
FA 18:0;O2
|
C18H36O4
|
316.261361
|
|
LMFA01050527
|
threo-9,10-Dihydroxystearic acid
|
(9R,10R)-9,10-dihydroxyoctadecanoic acid
|
FA 18:0;O2
|
C18H36O4
|
316.261361
|
|
LMFA06000034
|
2,4-octadienal
|
2,4-octadienal
|
FAL 8:2
|
C8H12O
|
124.088815
|
|
LMFA06000023
|
6-heptenal
|
6-heptenal
|
FAL 7:1
|
C7H12O
|
112.088815
|
|
LMFA05000659
|
Falcarinolone
|
(9Z)-8-hydroxyheptadeca-1,9-dien-4,6-diyn-3-one
|
FOH 17:7;O
|
C17H22O2
|
258.161980
|
|
LMFA05000704
|
xi-7-Octen-2-ol
|
oct-7-en-2-ol
|
FOH 8:1
|
C8H16O
|
128.120115
|
|
LMFA12000024
|
3-Methylbutan-2-one
|
3-Methylbutan-2-one
|
|
C5H10O
|
86.073165
|
|
LMFA01050462
|
(S)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
(3S)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
FA 6:1;O2
|
C6H10O4
|
146.057910
|
|
LMFA01050462
|
(S)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
(3S)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
FA 6:1;O2
|
C6H10O4
|
146.057910
|
|
LMFA01050462
|
(S)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
(3S)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
FA 6:1;O2
|
C6H10O4
|
146.057910
|
|
LMFA01030259
|
10Z-pentadecenoic acid
|
10Z-pentadecenoic acid
|
FA 15:1
|
C15H28O2
|
240.208930
|
|
LMFA11000665
|
1-methyl-1-(2-methyl-2-propenyl)-cyclopentane
|
1-methyl-1-(2-methyl-2-propenyl)-cyclopentane
|
|
C10H18
|
138.140850
|
|
LMFA01050529
|
xi-5-Hydroxydodecanoic acid
|
5-hydroxydodecanoic acid
|
FA 12:0;O
|
C12H24O3
|
216.172545
|
|
LMFA12000019
|
3E-Hexene-2-one
|
3E-Hexene-2-one
|
|
C6H10O
|
98.073165
|
|
LMFA11000593
|
2,6-dimethyl-2-octene
|
2,6-dimethyl-2-octene
|
|
C10H20
|
140.156500
|
|
LMFA11000635
|
1,2,4-trimethylcyclohexane
|
1,2,4-trimethylcyclohexane
|
|
C9H18
|
126.140850
|
|
LMFA11000641
|
1alpha,2beta,4-beta-trimethylcyclohexane
|
1alpha,2beta,4-beta-trimethylcyclohexane
|
|
C9H18
|
126.140850
|
|
LMFA11000648
|
trans-1-ethyl-2-methycyclohexane
|
trans-1-ethyl-2-methycyclohexane
|
|
C9H18
|
126.140850
|
|
LMFA11000657
|
Butylcyclohexane
|
Butylcyclohexane
|
|
C10H20
|
140.156500
|
|
LMFA11000704
|
4-Methyl-5-propylnonane
|
4-Methyl-5-propylnonane
|
|
C13H28
|
184.219100
|
|
LMFA07010699
|
(2E,8Z)-Decadiene-4,6-diyn-1-yl 3-methylbutanoate
|
(2E,8Z)-deca-2,8-dien-4,6-diyn-1-yl 3-methylbutanoate
|
WE 15:6
|
C15H18O2
|
230.130680
|
|
LMFA07010699
|
(2E,8Z)-Decadiene-4,6-diyn-1-yl 3-methylbutanoate
|
(2E,8Z)-deca-2,8-dien-4,6-diyn-1-yl 3-methylbutanoate
|
WE 15:6
|
C15H18O2
|
230.130680
|
|
LMFA07010813
|
Citronellyl alpha-toluate
|
3,7-dimethyloct-6-en-1-yl 2-phenylacetate
|
WE 18:5
|
C18H26O2
|
274.193280
|
|
LMFA07010813
|
Citronellyl alpha-toluate
|
3,7-dimethyloct-6-en-1-yl 2-phenylacetate
|
WE 18:5
|
C18H26O2
|
274.193280
|
|
LMFA07010813
|
Citronellyl alpha-toluate
|
3,7-dimethyloct-6-en-1-yl 2-phenylacetate
|
WE 18:5
|
C18H26O2
|
274.193280
|
|
LMFA07010813
|
Citronellyl alpha-toluate
|
3,7-dimethyloct-6-en-1-yl 2-phenylacetate
|
WE 18:5
|
C18H26O2
|
274.193280
|
|
LMFA07070047
|
6-Keto-decanoylcarnitine
|
3-[(6-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1;O
|
C17H31NO5
|
329.220224
|
|
LMFA07070047
|
6-Keto-decanoylcarnitine
|
3-[(6-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1;O
|
C17H31NO5
|
329.220224
|
|
LMFA08020182
|
IC202A
|
N-(5-aminopentyl)-N'-(5-{[4-({5-[butylidene(oxido)-lambda(5)-azanyl]pentyl}amino)-4-oxobutanoyl](hydroxy)amino}pentyl)-N-hydroxybutanediamide
|
|
C27H52N6O7
|
572.389748
|
|
LMFA08020182
|
IC202A
|
N-(5-aminopentyl)-N'-(5-{[4-({5-[butylidene(oxido)-lambda(5)-azanyl]pentyl}amino)-4-oxobutanoyl](hydroxy)amino}pentyl)-N-hydroxybutanediamide
|
|
C27H52N6O7
|
572.389748
|
|
LMFA08020188
|
N-(3-carboxypropanoyl)-N-hydroxyputrescine
|
4-[(4-aminobutyl)(hydroxy)amino]-4-oxobutanoic acid
|
|
C8H16N2O4
|
204.111008
|
|
LMFA08020188
|
N-(3-carboxypropanoyl)-N-hydroxyputrescine
|
4-[(4-aminobutyl)(hydroxy)amino]-4-oxobutanoic acid
|
|
C8H16N2O4
|
204.111008
|
|
LMFA08010016
|
acetoacetamide
|
3-oxobutanamide
|
|
C4H7NO2
|
101.047679
|
|
LMFA08010016
|
acetoacetamide
|
3-oxobutanamide
|
|
C4H7NO2
|
101.047679
|
|
LMFA08010016
|
acetoacetamide
|
3-oxobutanamide
|
|
C4H7NO2
|
101.047679
|
|
LMFA07010752
|
3-Hexenyl 2-methylbutyrate
|
hex-3-en-1-yl 2-methylbutanoate
|
WE 11:1
|
C11H20O2
|
184.146330
|
|
LMFA07010752
|
3-Hexenyl 2-methylbutyrate
|
hex-3-en-1-yl 2-methylbutanoate
|
WE 11:1
|
C11H20O2
|
184.146330
|
|
LMFA07010752
|
3-Hexenyl 2-methylbutyrate
|
hex-3-en-1-yl 2-methylbutanoate
|
WE 11:1
|
C11H20O2
|
184.146330
|
|
LMFA07010818
|
Citronellyl isovalerate
|
3,7-dimethyloct-6-en-1-yl 3-methylbutanoate
|
WE 15:1
|
C15H28O2
|
240.208930
|